BACKGROUND: China has low seasonal influenza vaccination rates among priority populations. In this study, we aimed to evaluate a pay-it-forward strategy to increase influenza vaccine uptake in rural, suburban, and urban settings in China. METHODS: We performed a quasi-experimental pragmatic trial to examine the effectiveness of a pay-it-forward intervention (a free influenza vaccine and an opportunity to donate financially to support vaccination of other individuals) to increase influenza vaccine uptake compared with standard-of-care user-paid vaccination among children (aged between 6 months and 8 years) and older people (≥60 years) in China. Recruitment took place in the standard-of-care group until the expected sample size was reached and then in the pay-it-forward group in primary care clinics from a rural site (Yangshan), a suburban site (Zengcheng), and an urban site (Tianhe). Participants were introduced to the influenza vaccine by project staff using a pamphlet about influenza vaccination and were either asked to pay out-of-pocket at the standard market price (US8⋅5−23⋅2;standard−of−caregroup)ortodonateanyamountanonymously(pay−it−forwardgroup).Participantshadtobeeligibletoreceiveaninfluenzavaccineandtohavenotreceivedaninfluenzavaccineinthepastyear.Theprimaryoutcomewasvaccineuptake.Secondaryoutcomeswerevaccineconfidenceandcosts(fromthehealth−careproviderperspective).Regressionmethodscomparedinfluenzavaccineuptakeandvaccineconfidencebetweenthetwogroups.ThistrialisregisteredwithChiCTR,ChiCTR2000040048.FINDINGS:FromSept21,2020,toMarch3,2021,300enroleeswererecruitedfrompatientsvisitingthreeprimarycareclinics.55(3745·60) than did the standard-of-care group ($64·67). INTERPRETATION: The pay-it-forward intervention seemed to be effective in improving influenza vaccine uptake and community engagement. Our data have implications for prosocial interventions to enhance influenza vaccine uptake in countries where influenza vaccines are available for a fee. FUNDING: Bill & Melinda Gates Foundation and the UK National Institute for Health Research